Further investigation of the markers involved in TB in vivo is thus required, including the development of an in vivo oral cancer xenograft model in immunodeficient mice by inducing p-EMT with TGF-β and using 3D cultures, which are more similar to the in vivo situation. This evidence concerns the gene TGFB1 and lip and oral cavity carcinoma.